Leaderboards/gastric cancer management and outcomes

gastric cancer management and outcomes

Last updated June 2, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
William D. Chey
Michigan Medicine
99
2
Shailja C. Shah
VA San Diego Healthcare System
90
3
Jeremy L. Davis
National Institutes of Health
80
4
Carrie E. Ryan
National Institutes of Health
70
5
Lin Shen
Unknown
50
6
Alanna Ebigbo
University Hospital Augsburg
40
7
Sung Hak Lee
St. Mary's Hospital
30
8
Jyh‐Ming Liou
National Taiwan University
20
9
Ming‐Shiang Wu
National Taiwan University
10

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
David C. Whitcomb
University of Pittsburgh
99
2
Cristina Díaz del Arco
Universidad Complutense de Madrid
90
3
Yi Wan
Harvard University
80
4
Satish Nagula
Icahn School of Medicine at Mount Sinai
70
5
John K. Triantafillidis
Senologic Hellenic Society
50
6
Yasser Fakri Mustafa
University of Mosul
30
7
Yoshinaga Okugawa
Mie University
20
8
Reem Z. Sharaiha
Cornell University
10

Emerging Leaders Papers

1
Early-onset gastrointestinal cancer: An epidemiological reality with great significance and implications
World Journal of Gastrointestinal Oncology|2024
13 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Anthony E. Reeve
University of Otago
99
2
Rohit Loomba
University of California San Diego
90
3
Andrés Cervantes
Universitat de València
80
4
Dirk Arnold
Asklepios Klinik Altona
70
5
Richard E. Sampliner
American College of Gastroenterology
60
6
N. Colombo
European Institute of Oncology
50
7
Michael B. Fallon
Unknown
40
8
Marcelo F. Vela
Baylor College of Medicine
30
9
William M. Lee
The University of Texas Southwestern Medical Center
20
10
Elizabeth Smyth
Cambridge University Hospitals NHS Foundation Trust
10

All-Time Leaders Papers

1
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
Hepatology|2017
1.9k cit.
2
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials
Annals of Oncology|2017
829 cit.
3
Acute liver failure
Hepatology|2008
752 cit.
4
Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis
Hepatology|2017
369 cit.
5
Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression
Modern Pathology|2018
41 cit.
6
The developmental programme for genesis of the entire kidney is recapitulated in Wilms tumour
PLoS ONE|2017
20 cit.
7
Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategy
Cancer Medicine|2019
4 cit.

Reagents for gastric cancer management and outcomes

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling Technology

OLFM4 (D1E4M) Rabbit Monoclonal Antibody

#14369$178
View Evidence →

⭐ Recommended

Best all-around

Cell Signaling Technology

Stat3 (D1B2J) Rabbit Monoclonal Antibody

Cited in 5 papers
#30835$167
View Evidence →Cell Signaling Technology

Bax Antibody

#2774$317
View Evidence →Agilent/Dako

p53 Tumor Suppressor Protein

#M7001
View Evidence →

🌟 All-Time

Most validated

Roche

VENTANA® anti-BRAF V600E (VE1) Mouse Monoclonal Primary Antibody

Cited in 6 papers
#760-5095 (also 08033706001)
View Evidence →Cell Signaling Technology

BAF Antibody

Cited in 6 papers
#62935$317
View Evidence →Cell Signaling Technology

Rb (4H1) Mouse Monoclonal Antibody (BSA and Azide Free)

Cited in 6 papers
#61121$865
View Evidence →